KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation

César Serrano, Yuexiang Wang, Adrián Mariño-Enríquez, Jen Chieh Lee, Gloria Ravegnini, Jeffrey A. Morgan, Monica M. Bertagnolli, Carol Beadling, George D. Demetri, Christopher L. Corless, Michael C. Heinrich, Jonathan A. Fletcher

Research output: Contribution to journalArticle

25 Scopus citations
Original languageEnglish (US)
Pages (from-to)e93-e96
JournalJournal of Clinical Oncology
Volume33
Issue number22
DOIs
StatePublished - Aug 1 2015

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this